Comment
. 2007 Mar;101(3):681-2; author reply 683.
doi: 10.1016/j.rmed.2006.10.025.
Epub 2006 Dec 12.
Post hoc analysis and claims of superiority in the EXCEL trial
- PMID: 17166708
- DOI: 10.1016/j.rmed.2006.10.025
Item in Clipboard
Comment
Post hoc analysis and claims of superiority in the EXCEL trial
Respir Med.
2007 Mar.
Free article
No abstract available
Comment on
-
EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.Respir Med. 2006 Jul;100(7):1152-62. doi: 10.1016/j.rmed.2006.03.001. Epub 2006 May 3. Respir Med. 2006. PMID: 16675212 Clinical Trial.
Similar articles
-
Economic evaluations.Can Respir J. 2007 Jul-Aug;14(5):264-6. doi: 10.1155/2007/107253. Can Respir J. 2007. PMID: 17874484 Free PMC article. Review. No abstract available.
-
Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.J Asthma. 2010 Mar;47(2):217-23. doi: 10.3109/02770900903497154. J Asthma. 2010. PMID: 20170333 Clinical Trial.
-
EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.Respir Med. 2006 Jul;100(7):1152-62. doi: 10.1016/j.rmed.2006.03.001. Epub 2006 May 3. Respir Med. 2006. PMID: 16675212 Clinical Trial.
-
Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.Chest. 2013 Dec;144(6):1795-1802. doi: 10.1378/chest.13-0505. Chest. 2013. PMID: 24077095 Clinical Trial.
-
[symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.Drug Ther Bull. 2002 Aug;40(8):62-4. Drug Ther Bull. 2002. PMID: 12216339 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
